Key molecular dynamic could boost cancer treatments while limiting stem cell transplant rejection

A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell transplantation, according to the latest finding published by a team of scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI). The findings could have resounding impacts on allogeneic hematopoietic stem cell transplantation (allo-HSCT) and CAR-T cell therapy, according to the data.